Coronary Guidewire Clinical Trial Analysis

Summary

Global Markets Direct's "Coronary Guidewire Clinical Trials Analysis" is an essential source of data and information pertaining to product clinical trials being carried out by Coronary Guidewire manufacturers, globally. The report provides exhaustive information on each clinical investigation study with coverage detailed coverage on the pipeline products these trials are being carried out for.

Scope

• The report provides analysis and review of the key clinical trials being carried out globally and across key Coronary Guidewire market categories - Coronary Guidewire
• The report covers information on each product being clinically tested with detailed coverage on the pipeline product profile, the indication it's being investigated for etc.
• The report provides an in-depth analysis of the clinical trials with information on trial phase, trial 0status, trial acronym, purpose, inclusion and exclusion criteria, description, design, intervention, investigator information, primary and secondary end-points and trial results
• The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Global Markets Direct's team of industry experts.

Reasons to Buy

• Effectively plan your Mergers and Acquisitions and partnership strategies by identifying companies with the most promising pipeline.
• Stay ahead of the information curve in the fast changing Coronary Guidewire market.
• Plan in-licensing and out-licensing opportunities through review of pipeline products and technologies.
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
• Proactively plan and execute your competitive strategies by identifying clinical trials status of the leading competitive products in pipeline.
• Stay ahead of competition by understanding the changing competitive landscape in specific geographies.

Contents

• 1 List of Tables
• 1.2 List of Figures
• 2 Coronary Guidewire Clinical Trials
  • 2.1 Coronary Guidewire Clinical Trial By Equipment Type
  • 2.2 Coronary Guidewire Clinical Trials By Trial Phase and Trial Status
  • 2.3 Coronary Guidewire Pipeline Products By Development Stage
  • 2.4 Coronary Guidewire Pipeline Products By Therapy Area
  • 2.5 Coronary Guidewire Pipeline Products By News Summary
  • 2.6 Coronary Guidewire Lightwire
    • 2.6.1 The LightWire technology for catheter-based interventions
  • 2.7 Coronary Guidewire Safe-Cross RF CTO System-next generation
    • 2.7.1 The Prospective Study On Guided Radiofrequency Energy Ablation Of Total Occlusions (Great) Trial
• 3 Recent Developments
  • 3.1 Product News
    • 3.1.1 Dec 02, 2008: SafeSept Transseptal Guidewire Receives US FDA Market Clearance
    • 3.1.2 Sep 17, 2007: Interventional & Surgical Innovations, LLC (ISI) Announces The Signing Of A New Technology Agreement With Dr. Juan Parodi
  • 3.2 Product Approvals
    • 3.2.1 Dec 02, 2008: SafeSept Transseptal Guidewire Receives US FDA Market Clearance
• 4 Appendix
  • 4.1 Methodology
    • 4.1.1 Coverage
    • 4.1.2 Secondary Research
    • 4.1.3 Primary Research
    • 4.1.4 Expert Panel Validation
  • 4.2 Contact Us
  • 4.3 About Global Markets Direct
  • 4.4 Disclaimer
• 1 List of Tables
  • Table 1: Coronary Guidewire Clinical Trial By Equipment Type
  • Table 2: Coronary Guidewire Clinical Trials By Trial Phase and Trial Status
  • Table 3: Coronary Guidewire Pipeline Products By Development Stage
  • Table 4: Coronary Guidewire Pipeline Products By Therapy Area
  • Table 5: Coronary Guidewire Pipeline Products By News Summary
  • Table 6: Lightwire - The LightWire technology for catheter-based interventions
  • Table 7: Safe-Cross RF CTO System-next generation - The Prospective Study On Guided Radiofrequency Energy Ablation Of Total Occlusions (Great) Trial
• 1.2 List of Figures
  • Figure 1: Global Markets Direct Methodology